Know Cancer

or
forgot password

    • cancer clinical trials in denver, CO

    • Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
    Denver, Colorado 80218
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    University of Colorado
    Denver, Colorado 80217
    Pancreatic Cancer
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    University of Colorado Cancer Center
    Denver, Colorado 80262
    Breast Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - Rocky Mountain Cancer Center-Midtown

    Trial Locations
    US Oncology - Rocky Mountain Cancer Center-Midtown
    US Oncology - Rocky Mountain Cancer Center-Rose
    Multiple Myeloma
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    Rose Medical Center

    Trial Locations
    Rose Medical Center
    Presbyterian - Saint Lukes Medical Center - Health One
    Saint Anthony Central Hospital
    Exempla Saint Joseph Hospital
    Colorado Cancer Research Program CCOP
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery
    Porter Adventist Hospital

    Trial Locations
    Porter Adventist Hospital
    Presbyterian - St. Luke's Medical Center
    St. Joseph Hospital
    Rose Medical Center
    St. Anthony Central Hospital
    Head and Neck Cancer, Precancerous Condition
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    Porter Adventist Hospital

    Trial Locations
    Porter Adventist Hospital
    Presbyterian - St. Luke's Medical Center
    St. Joseph Hospital
    Rose Medical Center
    St. Anthony Central Hospital
    Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Presbyterian - St. Luke's Medical Center

    Trial Locations
    Presbyterian - St. Luke's Medical Center
    St. Joseph Hospital
    Rose Medical Center
    St. Anthony Central Hospital
    Kaiser Permanente - Denver
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
    University of Colorado Cancer Center
    Denver, Colorado 80262
    Ovarian Cancer, Fallopian Cancer, Peritoneal Cancer
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    Porter Adventist Hospital

    Trial Locations
    Porter Adventist Hospital
    Presbyterian - St. Luke's Medical Center
    St. Joseph Hospital
    Rose Medical Center
    St. Anthony Central Hospital
    Breast Cancer
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Presbyterian - St. Luke's Medical Center

    Trial Locations
    Presbyterian - St. Luke's Medical Center
    St. Joseph Hospital
    Rose Medical Center
    St. Anthony Central Hospital
    Kaiser Permanente - Denver
    Lung Cancer
    Reducing Breast Cancer Recurrence With Weight Loss
    University of Colorado Denver
    Denver, Colorado 80262
    Breast Cancer, Overweight, Obesity
    Tracking Renal Tumors After Cryoablation Evaluation
    Kaiser Permanente
    Denver, Colorado 80204-4507
    Kidney Neoplasms
    Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia

    Denver, Colorado
    Relapsed Multiple Myeloma, Refractory Multiple Myeloma, Waldenstrom Macroglobulinemia
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    University of Colorado
    Denver, Colorado 80217
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    CCOP - Colorado Cancer Research Program

    Trial Locations
    CCOP - Colorado Cancer Research Program
    Porter Adventist Hospital
    Presbyterian - St. Luke's Medical Center
    St. Joseph Hospital
    Rose Medical Center
    St. Anthony Central Hospital
    Kidney Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Porter Adventist Hospital

    Trial Locations
    Porter Adventist Hospital
    Presbyterian - St. Luke's Medical Center
    St. Joseph Hospital
    Rose Medical Center
    St. Anthony Central Hospital
    Breast Cancer